Paper20554145
Molecular imaging of cancer: MR spectroscopy and beyond.
Pinker K and 4 others. Eur J Radiol, 2012. Cited by 45 papers, by iCite.
Cite this record
ConductScience Library. Molecular imaging of cancer: MR spectroscopy and beyond. Papers, record 20554145. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20554145
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Magnetic Resonance Spectroscopy | Major topic |
| Molecular Imaging | Major topic |
| Neoplasms | Major topic |
| Contrast Media | |
| Diffusion Magnetic Resonance Imaging | |
| Humans | |
| Sensitivity and Specificity | |
| Sodium |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41966642 | MR-based techniques for imaging prostate cancer metabolism: current status and future perspectives. | Abdom Radiol (NY) | 2026 | https://conductscience.org/library/papers/41966642 | PubMed |
| 34374098 | Multi-parametric MRI (mpMRI) for treatment response assessment of radiation therapy. | Med Phys | 2022 | https://conductscience.org/library/papers/34374098 | PubMed |
| 33194769 | Manganese-Based Targeted Nanoparticles for Postoperative Gastric Cancer Monitoring via Magnetic Resonance Imaging. | Front Oncol | 2020 | https://conductscience.org/library/papers/33194769 | PubMed |
| 32899427 | Radioresistance in Glioblastoma and the Development of Radiosensitizers. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32899427 | PubMed |
| 32751723 | Clinical Feasibility of Reduced Field-of-View Diffusion-Weighted Magnetic Resonance Imaging with Computed Diffusion-Weighted Imaging Technique in Breast Cancer Patients. | Diagnostics (Basel) | 2020 | https://conductscience.org/library/papers/32751723 | PubMed |
| 29393071 | MRI-only treatment planning: benefits and challenges. | Phys Med Biol | 2018 | https://conductscience.org/library/papers/29393071 | PubMed |
| 29229179 | Clinical role of breast MRI now and going forward. | Clin Radiol | 2018 | https://conductscience.org/library/papers/29229179 | PubMed |
| 27805423 | The potential of multiparametric MRI of the breast. | Br J Radiol | 2017 | https://conductscience.org/library/papers/27805423 | PubMed |
| 27399100 | Analysis of factors influencing the degree of detectability on diffusion-weighted MRI and diffusion background signals in patients with invasive breast cancer. | Medicine (Baltimore) | 2016 | https://conductscience.org/library/papers/27399100 | PubMed |
| 27372708 | Evaluation of diffusion-weighted imaging (DWI) and MR spectroscopy (MRS) as early response biomarkers in cervical cancer patients. | Radiol Med | 2016 | https://conductscience.org/library/papers/27372708 | PubMed |
| 27364727 | [Multiparametric and molecular imaging of breast tumors with MRI and PET/MRI]. | Radiologe | 2016 | https://conductscience.org/library/papers/27364727 | PubMed |
| 26712681 | Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer? | Diagn Interv Radiol | 2016 | https://conductscience.org/library/papers/26712681 | PubMed |
| 26687855 | The Potential of Metabolic Imaging. | Semin Nucl Med | 2016 | https://conductscience.org/library/papers/26687855 | PubMed |
| 26589201 | [Multiparametric imaging with simultaneous MRI/PET: Methodological aspects and possible clinical applications]. | Z Rheumatol | 2015 | https://conductscience.org/library/papers/26589201 | PubMed |
| 26413543 | MRI for Crohn's Disease: Present and Future. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/26413543 | PubMed |
| 25608557 | The role of magnetic resonance imaging in the management of brain metastases: diagnosis to prognosis. | Cancer Imaging | 2014 | https://conductscience.org/library/papers/25608557 | PubMed |
| 24557495 | [Molecular breast imaging. An update]. | Radiologe | 2014 | https://conductscience.org/library/papers/24557495 | PubMed |
| 23970895 | SIVIC: Open-Source, Standards-Based Software for DICOM MR Spectroscopy Workflows. | Int J Biomed Imaging | 2013 | https://conductscience.org/library/papers/23970895 | PubMed |
| 23949435 | [Multiparametric imaging with simultaneous MR/PET. Methodological aspects and possible clinical applications]. | Radiologe | 2013 | https://conductscience.org/library/papers/23949435 | PubMed |
| 23740024 | Preliminary observations and clinical value of lipid peak in high-grade uterine sarcomas using in vivo proton MR spectroscopy. | Eur Radiol | 2013 | https://conductscience.org/library/papers/23740024 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20554145
GET https://conductscience.org/api/papers/v1/20554145/cited_by?page=2